Puncher for cell line Development (Q3989339): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Fixing summary)
(‎Changed an Item: Adding English translations)
Property / summary
 
In this project, a Puncher platform demonstrator will be realised and validated to develop antibody-producing monoclonal cell lines more quickly and cost effectively. Antibodies are used in the treatment of... (English)
Property / summary: In this project, a Puncher platform demonstrator will be realised and validated to develop antibody-producing monoclonal cell lines more quickly and cost effectively. Antibodies are used in the treatment of... (English) / rank
 
Normal rank
Property / summary: In this project, a Puncher platform demonstrator will be realised and validated to develop antibody-producing monoclonal cell lines more quickly and cost effectively. Antibodies are used in the treatment of... (English) / qualifier
 
point in time: 15 December 2021
Timestamp+2021-12-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 06:16, 15 December 2021

Project Q3989339 in Netherlands
Language Label Description Also known as
English
Puncher for cell line Development
Project Q3989339 in Netherlands

    Statements

    0 references
    0 references
    283,786.04 Euro
    0 references
    1,542,992.97 Euro
    0 references
    18.392 percent
    0 references
    11 May 2020
    0 references
    30 June 2023
    0 references
    JB Ventures
    0 references
    Q3986709 (Deleted Item)
    0 references

    52°21'31.14"N, 6°30'15.73"E
    0 references
    7442CL
    0 references
    In dit project zal een Puncher platform demonstrator worden gerealiseerd en gevalideerd om hiermee antilichaam producerende monoclonale cellijnen sneller en kosten effectiever te ontwikkelen. Antilichamen worden gebruikt bij de behandeling van kan... (Dutch)
    0 references
    In this project, a Puncher platform demonstrator will be realised and validated to develop antibody-producing monoclonal cell lines more quickly and cost effectively. Antibodies are used in the treatment of... (English)
    15 December 2021
    0 references

    Identifiers

    OP-2014-2023-Oost-PROJ-00971
    0 references